Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex
暂无分享,去创建一个
E. Henske | J. Bissler | E. Zhang | Jane J Yu | M. Soleimani | Sharon Barone | Yirong Yang | K. Zahedi | Marybeth Brooks | Jane J. Yu | Sharon L. Barone
[1] Ming-Zhi Zhang,et al. Notch signaling is essential in collecting duct epithelial cell fate determination during development and maintenance of cell type homeostasis in adult. , 2019, Annals of translational medicine.
[2] B. Siroky,et al. Tuberous sclerosis complex exhibits a new renal cystogenic mechanism , 2019, Physiological reports.
[3] Divya Kota,et al. Endogenous Notch Signaling in Adult Kidneys Maintains Segment-Specific Epithelial Cell Types of the Distal Tubules and Collecting Ducts to Ensure Water Homeostasis. , 2018, Journal of the American Society of Nephrology : JASN.
[4] Marie E. Edwards,et al. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease. , 2018, Clinical journal of the American Society of Nephrology : CJASN.
[5] Pontus Eriksson,et al. Cell-Type-Specific Gene Programs of the Normal Human Nephron Define Kidney Cancer Subtypes. , 2017, Cell reports.
[6] J. Peters. The (pro)renin receptor and its interaction partners , 2017, Pflügers Archiv - European Journal of Physiology.
[7] Q. Al-Awqati,et al. Transcription factor TFCP2L1 patterns cells in the mouse kidney collecting ducts , 2017, eLife.
[8] F. Reis,et al. Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis Complex , 2017, Oxidative medicine and cellular longevity.
[9] P. Ashton-Prolla,et al. TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review , 2017, Genetics and molecular biology.
[10] G. Seki,et al. Functional coupling of V-ATPase and CLC-5 , 2017, World journal of nephrology.
[11] E. Henske,et al. New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex , 2017, The Journal of pathology.
[12] A. Sangoi,et al. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms. , 2016, Pathology, research and practice.
[13] D. Kohan,et al. The nephron (pro)renin receptor: function and significance. , 2016, American journal of physiology. Renal physiology.
[14] J. Bissler,et al. Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review , 2016, Therapeutic advances in urology.
[15] F. Trepiccione,et al. Renal Atp6ap2/(Pro)renin Receptor Is Required for Normal Vacuolar H+-ATPase Function but Not for the Renin-Angiotensin System. , 2016, Journal of the American Society of Nephrology : JASN.
[16] M. Brucker,et al. The Past and the Future. , 2016, Nursing for women's health.
[17] E. Thiele,et al. Tuberous Sclerosis Complex , 2019, Harper's Textbook of Pediatric Dermatology.
[18] E. Roach,et al. Tuberous sclerosis complex. , 2015, Handbook of clinical neurology.
[19] L. Lagae,et al. Tuberous sclerosis complex: the past and the future , 2015, Pediatric Nephrology.
[20] S. Grinstein,et al. The vacuolar-type H+-ATPase at a glance – more than a proton pump , 2014, Journal of Cell Science.
[21] Tetsuhiro Tanaka,et al. ANO1: an additional key player in cyst growth. , 2014, Kidney international.
[22] Cuilan Yang,et al. Activation of mTORC1 in collecting ducts causes hyperkalemia. , 2014, Journal of the American Society of Nephrology : JASN.
[23] R. Rasooly,et al. Tuberous sclerosis complex, mTOR, and the kidney: report of an NIDDK-sponsored workshop. , 2014, American journal of physiology. Renal physiology.
[24] M. Soleimani,et al. Double Knockout of Carbonic Anhydrase II (CAII) and Na+-Cl- Cotransporter (NCC) Causes Salt Wasting and Volume Depletion , 2013, Cellular Physiology and Biochemistry.
[25] Dennis Brown,et al. Regulation of luminal acidification by the V-ATPase. , 2013, Physiology.
[26] B. Manning,et al. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output , 2013, Nature Cell Biology.
[27] David Chen,et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial , 2013, The Lancet.
[28] M. Bader,et al. (Pro)renin receptor: subcellular localizations and functions. , 2013, Frontiers in bioscience.
[29] E. Hoorn,et al. Key developments in renin–angiotensin–aldosterone system inhibition , 2013, Nature Reviews Nephrology.
[30] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[31] M. Soleimani,et al. Slc26a11, a chloride transporter, localizes with the vacuolar H(+)-ATPase of A-intercalated cells of the kidney. , 2011, Kidney international.
[32] Roberto Zoncu,et al. mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase , 2011, Science.
[33] D. Corey,et al. Regulation of TFEB and V-ATPases by mTORC1 , 2011, The EMBO journal.
[34] B. Viollet,et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.
[35] Paul Landais,et al. Extended Report , 2022 .
[36] J. Bissler,et al. Tuberous Sclerosis Complex Renal Disease , 2010, Nephron Experimental Nephrology.
[37] Y. Kong,et al. Inactivation of Notch signaling in the renal collecting duct causes nephrogenic diabetes insipidus in mice. , 2009, The Journal of clinical investigation.
[38] B. Rutkowski,et al. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex. , 2009, Transplantation proceedings.
[39] T. Schüpbach,et al. The vacuolar proton pump, V-ATPase, is required for notch signaling and endosomal trafficking in Drosophila. , 2009, Developmental cell.
[40] O. Devuyst,et al. Regulated acid–base transport in the collecting duct , 2009, Pflügers Archiv - European Journal of Physiology.
[41] Sylvie Breton,et al. The Forkhead Transcription Factor Foxi1 Is a Master Regulator of Vacuolar H+-ATPase Proton Pump Subunits in the Inner Ear, Kidney and Epididymis , 2009, PloS one.
[42] L. Cantley,et al. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. , 2008, Human molecular genetics.
[43] Vincent J Schmithorst,et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. , 2008, The New England journal of medicine.
[44] Michael Forgac,et al. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology , 2007, Nature Reviews Molecular Cell Biology.
[45] K. Guan,et al. Expanding mTOR signaling , 2007, Cell Research.
[46] S. Petrovic,et al. Chloride/bicarbonate exchanger SLC26A7 is localized in endosomes in medullary collecting duct cells and is targeted to the basolateral membrane in hypertonicity and potassium depletion. , 2006, Journal of the American Society of Nephrology : JASN.
[47] J. Bissler,et al. Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[48] P. Courtoy,et al. Ubiquitous and kidney-specific subunits of vacuolar H+-ATPase are differentially expressed during nephrogenesis. , 2005, Journal of the American Society of Nephrology : JASN.
[49] D. Kwiatkowski,et al. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. , 2005, Human molecular genetics.
[50] J. Avruch,et al. Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency* , 2005, Journal of Biological Chemistry.
[51] U. Kornak,et al. Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone. , 2005, Journal of the American Society of Nephrology : JASN.
[52] D. Kwiatkowski,et al. A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes. , 2005, Human molecular genetics.
[53] E. Hafen,et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. , 2004, Genes & development.
[54] N. Sonenberg,et al. Upstream and downstream of mTOR. , 2004, Genes & development.
[55] G. Schwartz,et al. A fork in the road of cell differentiation in the kidney tubule. , 2004, The Journal of clinical investigation.
[56] G. Bergström,et al. Distal renal tubular acidosis in mice that lack the forkhead transcription factor Foxi1. , 2004, The Journal of clinical investigation.
[57] J. Blenis,et al. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.
[58] G. Schwartz,et al. Distal renal tubular acidosis , 2004, Current opinion in pediatrics.
[59] K. Inoki,et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.
[60] J. Blenis,et al. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. , 2002, Genes & development.
[61] J. Frøkiaer,et al. Aquaporins in the kidney: from molecules to medicine. , 2002, Physiological reviews.
[62] M. Soleimani,et al. Fasting downregulates renal water channel AQP2 and causes polyuria. , 2001, American journal of physiology. Renal physiology.
[63] J. Frøkiaer,et al. Physiology and pathophysiology of renal aquaporins. , 1999, Journal of the American Society of Nephrology : JASN.
[64] Thomas J. Jentsch,et al. ClC-5 Cl--channel disruption impairs endocytosis in a mouse model for Dent's disease , 2000, Nature.
[65] Tobias Schmelzle,et al. TOR, a Central Controller of Cell Growth , 2000, Cell.
[66] L. A. Haddad,et al. Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney. , 2000, American journal of physiology. Renal physiology.
[67] H. Onda,et al. Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. , 1999, The Journal of clinical investigation.
[68] M. Yasui,et al. Aquaporin-6: An intracellular vesicle water channel protein in renal epithelia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[69] P. Courtoy,et al. Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. , 1999, Human molecular genetics.
[70] P. Stricklett,et al. Targeting Collecting Tubules Using the Aquaporin-2 Promoter , 1999, Nephron Experimental Nephrology.
[71] T. Jentsch,et al. ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[72] J. R. Bosqueiro,et al. Role of Cl− in Electrogenic H+ Secretion by Cortical Distal Tubule , 1997, The Journal of Membrane Biology.
[73] W. Sly,et al. Depletion of intercalated cells from collecting ducts of carbonic anhydrase II-deficient (CAR2 null) mice. , 1995, The American journal of physiology.
[74] P. Harris,et al. The molecular genetics of tuberous sclerosis. , 1994, Human molecular genetics.
[75] J. Rapola,et al. Polycystic disease of the kidney. Evaluation and classification based on nephron segment and cell-type specific markers. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[76] H. Lodish,et al. Subtypes of intercalated cells in rat kidney collecting duct defined by antibodies against erythroid band 3 and renal vacuolar H+-ATPase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[77] R. Erickson,et al. N-ethyl-N-nitrosourea-induced null mutation at the mouse Car-2 locus: an animal model for human carbonic anhydrase II deficiency syndrome. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[78] Robert C. Wolpert,et al. A Review of the , 1985 .